Migraine headache. Migraine without aura [common migraine]
Conditions
Interventions
Intervention 1: Placebo Group: Placebo syrup,15 milliliter/Tree times a day for 4 Weeks. Patients Will be Followed at Baseline and 4 Weeks after Starting Intervention. Intervention 2: Intervention Gr
Placebo
Treatment - Drugs
Placebo Group: Placebo syrup,15 milliliter/Tree times a day for 4 Weeks. Patients Will be Followed at Baseline and 4 Weeks after Starting Intervention.
Intervention Group:Citron juice syrup,15 mililitr /Three times a day for 4 weeks. Patients will be Followed at Baseline and 4 after Starting Intervention.
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age 15-65y; Informed consent persons; 2 headache attacks or more per month; having at least one of the gastrointestinal migraine headache criteria; Not suffering from Diabetes, asthma, COPD, bradycardia, MDD and other neurologic diseases like convulsion; Not pregnancy.Exclusion criteria:Sensitivity to propranolol; use other chemical/herbal drugs within study ; Sensitivity to formulations ingredients;Unpleasant formulation to patients and desire to exclude; Pregnancy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean duration (hour, each attack). Timepoint: baseline,end of follow up (4 weeks after staring intervention). Method of measurement: questionnaire.;Frequency of headache (per month). Timepoint: baseline,4 weeks after treatment. Method of measurement: questionnaire.;Mean intensity of headache attacks. Timepoint: baseline,4 weeks after treatment. Method of measurement: visual analogue scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mehrnaz Jafarpour
Shiraz School of Pharmacy
Outcome results
None listed